Ondine Biomedical (LON:OBI) Trading Up 4% – Time to Buy?

Ondine Biomedical Inc. (LON:OBI)’s share price was up 4% during mid-day trading on Monday . The stock traded as high as C$13.50 and last traded at C$13.00. Approximately 267,087 shares changed hands during mid-day trading, a decline of 13% from the average daily volume of 307,901 shares. The stock had previously closed at C$12.50.

Ondine Biomedical Stock Up 4.0%

The company’s 50 day moving average price is C$14.57 and its two-hundred day moving average price is C$12.48. The company has a quick ratio of 8.26, a current ratio of 1.36 and a debt-to-equity ratio of 25.95. The stock has a market cap of C$6.74 billion, a P/E ratio of -1.86 and a beta of 0.10.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.